Prognostic factors and treatment effects on survival in acute myeloid leukemia of M6 subtype: a retrospective study of 54 cases.

Colita, A; Belhabri, A; Chelghoum, Y; Charrin, C; Fiere, D; Thomas, X

Colita, A; Belhabri, A; Chelghoum, Y; Charrin, C; Fiere, D; Thomas, X.

Affiliation

Colita A; Service d'Hématologie, Hjpital Edouard Herriot, Lyon, France.

Ann Oncol ; 12(4): 451-5, 2001 Apr.

Article in En | MEDLINE | ID: mdl-11398875

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Leukemia, Erythroblastic, Acute/drug therapy; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor/metabolism; Female; Humans; Karyotyping; Leukemia, Erythroblastic, Acute/metabolism; Leukemia, Erythroblastic, Acute/mortality; Male; Middle Aged; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Leukemia, Erythroblastic, Acute Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Year: 2001 Document type: Article

Search on Google

XML

PubMed Links